How Arterial Hypertension and Obesity Contribute to Geriatric Syndromes
https://doi.org/10.37586/2949-4745-1-2024-13-21
Abstract
Arterial hypertension and obesity are well-established cardiovascular risk factors, but their impact on major geriatric syndromes in individuals over 60 is not well understood. The association between hypertension, obesity, and the development of frailty, sarcopenia, and cognitive impairment varies depending on age. As individuals age, the impact of cardiovascular factors on geriatric syndromes decreases or becomes less significant. This hypothesis is supported by a number of studies on centenarians. The review also examines the impact of hypertension and obesity on prognosis in older individuals.
About the Authors
E. S. Koniaeva
Russian Gerontology Research and Clinical Centre, Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Koniaeva Ekaterina S., MD, Laboratory of Biomarkers of Aging,
Moscow.
I. D. Strazhesko
Russian Gerontology Research and Clinical Centre, Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Strazhesko Irina D., MD, PhD, Deputy Director for translational medicine; Leading Researcher at the Department of Age-related diseases
Moscow.
Phone: +7(903)520-41-54
References
1. Vetrano DL, Palmer KM, Galluzzo L, et al. Hypertension and frailty: a systematic review and meta-analysis. BMJ Open. 2018;8(12):e024406. Published 2018 Dec 28. doi: 10.1136/bmjopen-2018-024406.
2. Ahmed AM, Ahmed D, Alfaris M, Holmes A, Aljizeeri A, AlMallah MH. Prevalence and predictors of frailty in a high-income developing country: A cross-sectional study. Qatar Med J. 2020;2019(3):20. Published 2020 Jan 23. doi: 10.5339/qmj.2019.20.
3. Kang MG, Kim SW, Yoon SJ, Choi JY, Kim KI, Kim CH. Association between Frailty and Hypertension Prevalence, Treatment, and Control in the Elderly Korean Population. Sci Rep. 2017;7(1):7542. Published 2017 Aug 8. doi: 10.1038/s41598-017-07449-5.
4. Kremer KM, Braisch U, Rothenbacher D, Denkinger M, Dallmeier D; ActiFE Study Group. Systolic Blood Pressure and Mortality in Community-Dwelling Older Adults: Frailty as an Effect Modifier. Hypertension. 2022;79(1):24-32. doi: 10.1161/HYPERTENSIONAHA.121.17530.
5. Shen F, Chen J, Yang R, Yang J, Li H. Association between control status of blood pressure and frailty among middle-aged and older adults with hypertension in China: a longitudinal study. BMJ Open. 2022;12(3):e056395. Published 2022 Mar 14. doi: 10.1136/bmjopen-2021-056395.
6. Ravindrarajah R, Hazra NC, Hamada S, et al. Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records. Circulation. 2017;135(24):2357-2368. doi: 10.1161/CIRCULATIONAHA.116.026687.
7. Han K, Park YM, Kwon HS, et al. Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS One. 2014;9(1):e86902. Published 2014 Jan 29. doi: 10.1371/journal.pone.0086902.
8. Kara M, Kara Ö, Ceran Y, et al. SARcopenia Assessment in Hypertension: The SARAH Study. Am J Phys Med Rehabil. 2023;102(2):130-136. doi: 10.1097/PHM.0000000000002045.
9. Han P, Yu H, Ma Y, et al. The increased risk of sarcopenia in patients with cardiovascular risk factors in Suburb-Dwelling older Chinese using the AWGS definition. Sci Rep. 2017;7(1):9592. Published 2017 Aug 29. doi: 10.1038/s41598-017-08488-8.
10. Wu X, Li X, Xu M, Zhang Z, He L, Li Y. Sarcopenia prevalence and associated factors among older Chinese population: Findings from the China Health and Retirement Longitudinal Study. PLoS One. 2021;16(3):e0247617. Published 2021 Mar 4. doi: 10.1371/journal.pone.0247617.
11. Bai T, Fang F, Li F, Ren Y, Hu J, Cao J. Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis. BMC Geriatr. 2020;20(1):279. Published 2020 Aug 6. doi: 10.1186/s12877-020-01672-y.
12. Ахмедов Т. А., Сагинбаев У. Р., Рукавишникова С. А., Локинская Л. С. Коморбидный фон патофизиологического взаимодействия саркопении и артериальной гипертензии у лиц пожилоговозраста.// Современные проблемы здравоохранения и медицинской статистики. — 2022. — №4.С.1-10. [Akhmedov T.A., Saginbaev U.R., Rukavishnikova1 S.A., Lokinskaya L.S. Comorbid background of pathophysiological interaction of sarcopenia and arterial hypertension in elderly person. Current problems of health care and medical statistics. 2022;(4):1-10. (In Russ.)] doi:10.24412/2312-2935-2022-4-1-10.
13. Sun X, Dong C, Levin BE, et al. Systolic Blood Pressure and Cognition in the Elderly: The Northern Manhattan Study [published correction appears in J Alzheimers Dis. 2021;84(2):915]. J Alzheimers Dis. 2021;82(2):689-699. doi: 10.3233/JAD-210252.
14. Kuo HK, Sorond F, Iloputaife I, Gagnon M, Milberg W, Lipsitz LA. Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci. 2004;59(11):1191-1194. doi: 10.1093/gerona/59.11.1191.
15. Obisesan TO, Obisesan OA, Martins S, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2008;56(3):501-509. doi: 10.1111/j.1532-5415.2007.01592.x.
16. Shang S, Li P, Deng M, Jiang Y, Chen C, Qu Q. The AgeDependent Relationship between Blood Pressure and Cognitive Impairment: A Cross-Sectional Study in a Rural Area of Xi'an, China. PLoS One. 2016;11(7):e0159485. Published 2016 Jul 20. doi: 10.1371/journal.pone.0159485.
17. Kritz-Silverstein D, Laughlin GA, McEvoy LK, BarrettConnor E. Sex and Age Differences in the Association of Blood Pressure and Hypertension with Cognitive Function in the Elderly: The Rancho Bernardo Study. J Prev Alzheimers Dis. 2017;4(3):165-173. doi: 10.14283/jpad.2017.6.
18. Kabayama M, Kamide K, Gondo Y, et al. The association of blood pressure with physical frailty and cognitive function in community-dwelling septuagenarians, octogenarians, and nonagenarians: the SONIC study. Hypertens Res. 2020;43(12):1421-1429. doi: 10.1038/s41440-020-0499-9.
19. Richmond R, Law J, Kay-Lambkin F. Higher blood pressure associated with higher cognition and functionality among centenarians in Australia. Am J Hypertens. 2011;24(3):299-303. doi: 10.1038/ajh.2010.236.
20. Huang CQ, Dong BR, Zhang YL, Wu HM, Liu QX, Flaherty JH. Cognitive impairment and hypertension among Chinese nonagenarians and centenarians. Hypertens Res. 2009;32(7):554-558. doi: 10.1038/hr.2009.72.
21. Peltz CB, Corrada MM, Berlau DJ, Kawas CH. Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors. Alzheimers Dement. 2012;8(2):87-94. doi: 10.1016/j.jalz.2011.02.008.
22. Köhler S, Baars MA, Spauwen P, Schievink S, Verhey FR, van Boxtel MJ. Temporal evolution of cognitive changes in incident hypertension: prospective cohort study across the adult age span. Hypertension. 2014;63(2):245-251. doi: 10.1161/HYPERTENSIONAHA.113.02096.
23. de Menezes ST, Giatti L, Brant LCC, et al. Hypertension, Prehypertension, and Hypertension Control: Association With Decline in Cognitive Performance in the ELSA-Brasil Cohort. Hypertension. 2021;77(2):672-681. doi: 10.1161/HYPERTENSIONAHA.120.16080.
24. Парфенов В.А., Старчина Ю.А. Когнитивные нарушения у пациентов с артериальной гипертензией и их лечение.// Неврология, Нейропсихиатрия, Психосоматика. — 2011. — 3(1)– C. 27–33. [Parfenov V.A., Starchina Y.A. Cognitive disorders in patients with essential hypertension and their treatment. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(1):27-33. (In Russ.)]. doi: 10.14412/2074-2711-2011-130.
25. Парфенов В.А., Остроумова Т.М., Остроумова О.Д., Павлеева Е.Е. Особенности клинической картины у пациентов среднего возраста с эссенциальной артериальной гипертензией. // Терапевтический архив. — 2018. — 9 — С. 15–26. [Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Pavleeva E.E. Features of the clinical picture in patients of middle age with essential hypertension. Therapeutic archive. 2018;90(9):15-26. (In Russ.)].
26. Ерусланова К.А. и др. Распространенность артериальной гипертензии и ортостатической гипотонии у супердолгожителей: предварительные результаты московского исследования 100-летних.// Артериальная гипертензия. —2020. — 26(1) — C. 37–42. [Eruslanova K.A., Matchekhina L.V., Kotovskaya Y.V., Runikhina N.K., Tkacheva O.N. Prevalence and coincidence of hypertension and orthostatic hypotension in pre- and centenarians and their effect on mortality: preliminary results of Moscow centenarian study. Arterial Hypertension. 2020;26(1):37-42. (In Russ.)] https://doi.org/10.18705/1607-419X-2020-26-1-37-42.
27. Stessman J, Bursztyn M, Gershinsky Y, HammermanRozenberg A, Jacobs JM. Hypertension and Its Treatment at Age 90 Years: Is There an Association with 5-Year Mortality?. J Am Med Dir Assoc. 2017;18(3):277.e13-277.e19. doi: 10.1016/j.jamda.2016.12.076.
28. van Vliet P, Westendorp RG, van Heemst D, de Craen AJ, Oleksik AM. Cognitive decline precedes late-life longitudinal changes in vascular risk factors. J Neurol Neurosurg Psychiatry. 2010;81(9):1028-1032. doi: 10.1136/jnnp.2009.182519.
29. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55(3):383-388. doi: 10.1111/j.1532-5415.2007.01069.x.
30. Воробьева Н.М., Ткачева О.Н., Котовская Ю.В. Как уровень артериального давления влияет на 5-летнюю выживаемость лиц старческого возраста и долгожителей?// Артериальная гипертензия. — 2019.–25(3) — C.232-245. [Vorobyeva N.M., Tkacheva O.N., Kotovskaya Yu.V. How does blood pressure level influence 5-year survival in the middle and late old age subjects? Arterial Hypertension. 2019;25(3):232-245. (In Russ.)] https://doi.org/10.18705/1607-419X-2019-25-3-232-245.
31. Odden MC, Rawlings AM, Arnold AM, et al. Patterns of Cardiovascular Risk Factors in Old Age and Survival and Health Status at 90. J Gerontol A Biol Sci Med Sci. 2020;75(11):2207-2214. doi: 10.1093/gerona/glaa043.
32. Ravindrarajah R, Hazra NC, Hamada S, et al. Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records. Circulation. 2017;135(24):2357-2368. doi: 10.1161/CIRCULATIONAHA.116.026687.
33. Алексанян Я.Н., Милеева Л.В.. Распространенность ожирения у пациентов пожилого возраста с синдромом старческой астении. // Смоленский медицинский альманах. — 2020. –№1–С. 14–16. [AleksanyanYa.N. Mileeva L.V. The prevalence of obesity in elderly patients with senile astenia syndrome. Smolenskij medicinskij al'manah. 2019; (1): 14-16. (In Russ.)].
34. Ткачева О. Н. и др. Распространенность гериатрических синдромов у лиц в возрасте старше 65 лет: первые результаты российского эпидемиологического исследования ЭВКАЛИПТ. // Российский кардиологический журнал. — 2020. — №10 — C. 168–178. [Tkacheva O.N., Vorob’eva N.M., Kotovskaya Yu.V., Ostroumova O.D., Chernyaeva M.S., Silyutina M.V., Chernov A.V., Testova S.G., Ovcharova L.N., Selezneva E.V. Prevalence of geriatric syndromes in persons over 65 years: the first results of the EVCALIPT study. Russian Journal of Cardiology. 2020;25(10):3985. (In Russ.)] https://doi.org/10.15829/1560-4071-2020-3985
35. Yuan L, Chang M, Wang J. Abdominal obesity, body mass index and the risk of frailty in community-dwelling older adults: a systematic review and meta-analysis. Age Ageing. 2021;50(4):1118-1128. doi: 10.1093/ageing/afab039.
36. Uchai S, Andersen LF, Hopstock LA, Hjartåker A. Body mass index, waist circumference and pre-frailty/frailty: the Tromsø study 1994-2016. BMJ Open. 2023;13(2):e065707. Published 2023 Jan 23. doi: 10.1136/bmjopen-2022-065707.
37. Strandberg TE, Sirola J, Pitkälä KH, Tilvis RS, Strandberg AY, Stenholm S. Association of midlife obesity and cardiovascular risk with old age frailty: a 26-year follow-up of initially healthy men. Int J Obes (Lond). 2012;36(9):1153-1157. doi: 10.1038/ijo.2012.83.
38. Boutin E, Natella PA, Schott AM, et al. Interrelations between body mass index, frailty, and clinical adverse events in older community-dwelling women: The EPIDOS cohort study. Clin Nutr. 2018;37(5):1638-1644. doi: 10.1016/j.clnu.2017.07.023.
39. Zaslavsky O, Rillamas-Sun E, LaCroix AZ, et al. Association Between Anthropometric Measures and Long-Term Survival in Frail Older Women: Observations from the Women's Health Initiative Study. J Am Geriatr Soc. 2016;64(2):277-284. doi: 10.1111/jgs.13930.
40. Dinu M, Colombini B, Pagliai G, et al. BMI, functional and cognitive status in a cohort of nonagenarians: results from the Mugello study. Eur Geriatr Med. 2021;12(2):379-386. doi: 10.1007/s41999-020-00417-9.
41. Sääksjärvi K, Härkänen T, Stenholm S, et al. Probable Sarcopenia, Obesity, and Risk of All-Cause Mortality: A Pooled Analysis of 4,612 Participants. Gerontology. 2023;69(6):706-715. doi: 10.1159/000527804.
42. Hamer M, O'Donovan G. Sarcopenic obesity, weight loss, and mortality: the English Longitudinal Study of Ageing. Am J Clin Nutr. 2017;106(1):125-129. doi: 10.3945/ajcn.117.152488.
43. Liu C, Wong PY, Chung YL, et al. Deciphering the «obesity paradox» in the elderly: A systematic review and meta-analysis of sarcopenic obesity. Obes Rev. 2023;24(2):e13534. doi: 10.1111/obr.13534.
44. Liu C, Cheng KY, Tong X, et al. The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity. Front Endocrinol (Lausanne). 2023;14:1077255. Published 2023 Mar 1. doi: 10.3389/fendo.2023.1077255.
45. Yoo MC, Won CW, Soh Y. Association of high body mass index, waist circumference, and body fat percentage with sarcopenia in older women. BMC Geriatr. 2022;22(1):937. Published 2022 Dec 5. doi: 10.1186/s12877-022-03643-x.
46. Ishii S, Tanaka T, Akishita M, et al. Metabolic syndrome, sarcopenia and role of sex and age: cross-sectional analysis of Kashiwa cohort study. PLoS One. 2014;9(11):e112718. Published 2014 Nov 18. doi: 10.1371/journal.pone.0112718.
47. Tai P, Yang S, Liu W, et al. Association of anthropometric and nutrition status indicators with cognitive functions in centenarians. Clin Nutr. 2021;40(4):2252-2258. doi: 10.1016/j.clnu.2020.10.004.
48. Zhou Y, Flaherty JH, Huang CQ, Lu ZC, Dong BR. Association between body mass index and cognitive function among Chinese nonagenarians/centenarians. Dement Geriatr Cogn Disord. 2010;30(6):517-524. doi: 10.1159/000322110.
49. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: nineyear follow-up data from the Kungsholmen Project. J Am Geriatr Soc. 2008;56(1):111-116. doi: 10.1111/j.1532-5415.2007.01458.x.
50. Estrella-Castillo DF, Gómez-de-Regil L. Comparison of body mass index range criteria and their association with cognition, functioning and depression: a cross-sectional study in Mexican older adults. BMC Geriatr. 2019;19(1):339. Published 2019 Dec 3. doi: 10.1186/s12877-019-1363-0.
51. Ткачева О.Н., Мхитарян Э.А., Исаев Р.И. и др. Распространенность когнитивных нарушений у лиц пожилого, старческого возраста и долгожителей. // Бюллетень Национального общества по изучению болезни Паркинсона и расстройств движений. — 2022. — №2 — С. 200–202. [Tkacheva O.N., Mkhitaryan E.A., Isaev R.I. et al. Rasprostranennost' kognitivnyh narushenij u lic pozhilogo, starcheskogo vozrasta i dolgozhitelej. Byulleten' Nacional'nogo obshchestva po izucheniyu bolezni Parkinsona i rasstrojstv dvizhenij. 2022;(2):200-202. (In Russ)] doi: 10.24412/2226-079X-2022-12466.
52. Liu M, He P, Zhou C, et al. Association of waist-calf circumference ratio with incident cognitive impairment in older adults. Am J Clin Nutr. 2022;115(4):1005-1012. doi: 10.1093/ajcn/nqac011.
53. Ma W, Zhang H, Wu N, et al. Relationship between obesityrelated anthropometric indicators and cognitive function in Chinese suburb-dwelling older adults. PLoS One. 2021;16(10):e0258922. Published 2021 Oct 27. doi: 10.1371/journal.pone.0258922.
54. Ерусланова К.А., Лузина А.В., Онучина Ю.С. и др. Состояние сердечно-сосудистой системы сверхдолгожителей Москвы: распространенность сердечно-сосудистых заболеваний и их факторов риска. // Российский кардиологический журнал. — 2021. — № 26(1S), C. 29–34. [Eruslanova K.A., Luzina A.V., Onuchina Yu.S. et al. Cardiovascular system status of long-livers in Moscow: the prevalence of cardiovascular diseases and their risk factors. Russian Journal of Cardiology. 2021;26(1S):4028. (In Russ.)] https://doi.org/10.15829/1560-4071-2021-4028.
55. Lv YB, Liu S, Yin ZX, et al. Associations of Body Mass Index and Waist Circumference with 3-Year All-Cause Mortality Among the Oldest Old: Evidence from a Chinese Community-Based Prospective Cohort Study. J Am Med Dir Assoc. 2018;19(8):672-678. e4. doi: 10.1016/j.jamda.2018.03.015.
56. Liu S, Cao W, Li Z, et al. Association between different adiposity measures and all-cause mortality risk among centenarians: A prospective cohort study. Clin Nutr. 2023;42(7):1219-1226. doi: 10.1016/j.clnu.2023.04.023.
57. Lisko I, Tiainen K, Stenholm S, Luukkaala T, Hervonen A, Jylhä M. Body mass index, waist circumference, and waist-to-hip ratio as predictors of mortality in nonagenarians: the Vitality 90+ Study. J Gerontol A Biol Sci Med Sci. 2011;66(11):1244-1250. doi: 10.1093/gerona/glr147.
58. Турушева А.В., Фролова Е.В. Влияние избыточного веса и ожирения на смертность у пожилых: результаты девятилетнего проспективного исследования ХРУСТАЛЬ. // Российский журнал гериатрической медицины.-2021.-№1 — С.44-52. [Turusheva A.V., Frolova E.V. Impact of overweight and obesity on mortality in older adults: results of a nine-year prospective the CRYSTAL study. Russian Journal of Geriatric Medicine. 2021;(1):44-52. (In Russ.)] https://doi.org/10.37586/2686-8636-1-2021-44-52.
59. Winter JE, MacInnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014;99(4):875-890. doi: 10.3945/ajcn.113.068122.
Review
For citations:
Koniaeva E.S., Strazhesko I.D. How Arterial Hypertension and Obesity Contribute to Geriatric Syndromes. Problems of Geroscience. 2024;(1):13-21. (In Russ.) https://doi.org/10.37586/2949-4745-1-2024-13-21
Views:
348
Email this article .jpg)
